American Society of Hematology, 2025 (ASH)7 - 9 December 2025
Etavopivat in Adolescents with Sickle Cell Disease: Emerging Safety and Efficacy Findings from the First Cohort of the Ongoing Phase 1/2 HIBISCUS Kids Study
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.